Chantzara G, Stroumpoulis K, Alexandrou N, Kokkinos L, Iacovidou N, Xanthos T
Department of Anesthesiology, "Elpis" General of Athens, Greece -
Minerva Anestesiol. 2014 May;80(5):547-55. Epub 2013 Nov 13.
Pharyngolaryngeal discomfort is a significant complication following the use of laryngeal mask airway (LMA). The present study aimed to investigate the relation of LMA cuff pressure and the occurrence of pharyngolaryngeal discomfort during spontaneous ventilation (SV), pressure support (PSV) and pressure control ventilation (PCV).
A hundred and twenty patients, ASA I-III, were included in this study. Originally the patients were divided into three groups: the 1st group was left to breath spontaneously, the 2nd group was placed under PSV while PCV was used in the 3rd group. Each group was divided into two subgroups: A) intervention group (maintaining cuff pressure at 60 cmH2O, measurement in 10 min intervals) and B) observation group (no intervention in cuff pressure, measurement in 10 min intervals). Anesthesia was induced with propofol and fentanyl and maintained with sevoflurane in air/oxygen. Patients were assessed 2 and 24 hours post-surgery, for sore throat, dysphonia or dysphagia.
A and B subgroup comparison at 24 hours revealed a statistically significant difference in the presence of pharyngolaryngeal discomfort in the PSV group (10% versus 55% respectively, P=0.006). Furthermore, when assessing the effect of maintaining a constant cuff pressure regardless of mode of ventilation, significantly fewer adverse effects were observed (8.3% vs. 35%, P=0.001) when compared to the non-intervention subgroup.
Maintaining LMA cuff pressure in values which do not exceed 60 cmH2O probably contributes in decreasing pharyngolaryngeal discomfort independently of ventilation mode. The ventilation mode which leads to the highest incidence of pharyngolaryngeal morbidity when cuff pressures are not closely monitored is PSV.
咽喉部不适是使用喉罩气道(LMA)后的一种重要并发症。本研究旨在探讨LMA套囊压力与自主通气(SV)、压力支持通气(PSV)和压力控制通气(PCV)期间咽喉部不适发生情况之间的关系。
本研究纳入了120例ASA I-III级患者。最初,患者被分为三组:第一组自主呼吸,第二组接受PSV,第三组使用PCV。每组又分为两个亚组:A)干预组(将套囊压力维持在60 cmH₂O,每隔10分钟测量一次)和B)观察组(不对套囊压力进行干预,每隔10分钟测量一次)。采用丙泊酚和芬太尼诱导麻醉,并用七氟醚在空气/氧气中维持麻醉。在术后2小时和24小时对患者进行咽喉疼痛、声音嘶哑或吞咽困难的评估。
24小时时A亚组和B亚组比较显示,PSV组在咽喉部不适的存在方面有统计学显著差异(分别为10%和55%,P = 0.006)。此外,在评估无论通气模式如何维持恒定套囊压力的效果时,与非干预亚组相比,观察到的不良反应明显更少(8.3%对35%,P = 0.001)。
将LMA套囊压力维持在不超过60 cmH₂O的水平可能有助于降低咽喉部不适,且与通气模式无关。当套囊压力未得到密切监测时,导致咽喉部发病率最高的通气模式是PSV。